Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.84 |
| ▸ | ESR2 | Q92731 | 8/20 | 0.60 |
| ▸ | ESR1 | P03372 | 7/20 | 0.60 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.54 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.54 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.54 |
| ▸ | TSHR | P16473 | 1/20 | 0.54 |
| ▸ | HSD17B1 | P14061 | 2/20 | 0.54 |
| ▸ | HSD17B2 | P37059 | 2/20 | 0.54 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.54 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.54 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.54 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.54 |
| ▸ | MEN1 | O00255 | 2/20 | 0.52 |
| ▸ | NPC1 | O15118 | 2/20 | 0.52 |
| ▸ | RAB9A | P51151 | 2/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
| ▸ | CLK1 | P49759 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3790145 | 1.00 | CYP1A2 (0.84) | CYP1A2ESR2ESR1CYP3A4ALOX15 | |
| SCHEMBL29410413 | 1.00 | CYP1A2 (0.84) | CYP1A2ESR2ESR1CYP3A4ALOX15 | |
| SCHEMBL536458 | 1.00 | CYP1A2 (0.84) | CYP1A2ESR2ESR1CYP3A4ALOX15 | |
| SCHEMBL31320915 | 1.00 | CYP1A2 (0.84) | CYP1A2ESR2ESR1CYP3A4ALOX15 | |
| Methane SCHEMBL7865282 | 0.97 | CYP1A2 (0.80) | CYP1A2ESR2ESR1CYP3A4ALOX15 | |
| Anthracene SCHEMBL28283702 | 0.97 | CYP1A2 (0.90) | CYP1A2ESR2ESR1CYP3A4ALOX15 | |
| Betanaphthol SCHEMBL11026449 | 0.94 | CYP1A2 (0.94) | CYP1A2ESR2ESR1CYP3A4ALOX15 | |
| Betanaphthol SCHEMBL11594695 | 0.92 | CYP1A2 (1.00) | CYP1A2ESR2ESR1CYP3A4ALOX15 | |
| Betanaphthol SCHEMBL28781 | 0.92 | CYP1A2 (1.00) | CYP1A2ESR2ESR1CYP3A4ALOX15 | |
| Betanaphthol SCHEMBL239472 | 0.92 | CYP1A2 (1.00) | CYP1A2ESR2ESR1CYP3A4ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2675800-A1 | FUNCTIONALIZED ANTHRACENE-CAPPED OLIGOTHIOPHENES AND ORGANIC SEMICONDUCTORS BASED ON THE SAME, USE THEREOF | Institute Of Chemistry, Chinese Academy Of Sciences (CN) | 2013-12-25 | — | — | EP | disclosed |
| US-20130331583-A1 | FUNCTIONALIZED ANTHRACENE-CAPPED OLIGOTHIOPHENES AND ORGANIC SEMICONDUCTORS BASED ON THE SAME, USE THEREOF | Institute of Chemistry, Chinesse Academy of Sciences | 2013-12-12 | — | — | US | disclosed |
| US-20130001472-A1 | THIN FILM AND COMPOUND USED IN THE SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2013-01-03 | — | — | US | disclosed |
| WO-2012079545-A1 | FUNCTIONALIZED ANTHRACENE-CAPPED OLIGOTHIOPHENES AND ORGANIC SEMICONDUCTORS BASED ON THE SAME, USE THEREOF | CHINESE ACADEMY OF SCIENCE INSTITUTE OF CHEMISTRY (CN) | 2012-06-21 | — | — | WO | disclosed |
| US-20100009927-A1 | Anti-Inflammatory and Anti-Allergy Extracts from Nettle | HERBALSCIENCE GROUP LLC (US) | 2010-01-14 | — | — | US | disclosed |
| EP-1906969-A4 | METHODS FOR TREATING AND DIAGNOSING COMPLICATIONS OF PREMATURE BIRTH | CHILDRENS MEDICAL CENTER (US) | 2009-07-29 | — | — | EP | disclosed |
| EP-1906969-A2 | METHODS FOR TREATING AND DIAGNOSING COMPLICATIONS OF PREMATURE BIRTH | CHILDREN'S MEDICAL CENTER CORPORATION (US) | 2008-04-09 | — | — | EP | disclosed |
| WO-2007011926-A2 | METHODS FOR TREATING AND DIAGNOSING COMPLICATIONS OF PREMATURE BIRTH | CHILDREN'S MEDICAL CENTER CORPORATION (US) | 2007-01-25 | — | — | WO | disclosed |
| US-7135581-B2 | Antiangiogenic agents | ENTREMED, INC. (US) | 2006-11-14 | — | — | US | disclosed |
| EP-1042354-A2 | ESTRONE SULFAMATE INHIBITORS OF ESTRONE SULFATASE, AND ASSOCIATED PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE | SRI INTERNATIONAL (US) | 2000-10-11 | — | — | EP | disclosed |
| WO-1999033858-A9 | ESTRONE SULFAMATE INHIBITORS OF ESTRONE SULFATASE, AND ASSOCIATED PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE | STANFORD RES INST INT (US) | 1999-10-28 | — | — | WO | disclosed |
| WO-1999033858-A2 | ESTRONE SULFAMATE INHIBITORS OF ESTRONE SULFATASE, AND ASSOCIATED PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE | SRI INTERNATIONAL (US) | 1999-07-08 | — | — | WO | disclosed |
| US-5338863-A | Catalytic sulfiding | CIBA-GEIGY CORPORATION (US) | 1994-08-16 | — | — | US | disclosed |
| US-5206390-A | Intermediates for tetrathiotetracenes | CIBA-GEIGY CORPORATION (US) | 1993-04-27 | — | — | US | disclosed |
| US-4617151-A | 2- or 2,3-substituted 5,6,11,12-tetrathiotetracene and 5,6,11,12-tetraselenotetracene | CIBA-GEIGY CORPORATION (US) | 1986-10-14 | — | — | US | disclosed |
| EP-0065243-B1 | ORGANIC PHOTOCONDUCTIVE COMPOSITIONS FOR USE IN ELECTROPHOTOGRAPHY | KABUSHIKI KAISHA TOSHIBA (JP) | 1985-08-28 | — | — | EP | disclosed |
| US-4465752-A | Organic photoconductive compositions for use in electrophotography | TOKYO SHIBAURA DENKI KABUSHIKI KAISHA (JP) | 1984-08-14 | — | — | US | disclosed |
| EP-0065243-A1 | Organic photoconductive compositions for use in electrophotography | KABUSHIKI KAISHA TOSHIBA (JP) | 1982-11-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130001472-A1 | THIN FILM AND COMPOUND USED IN THE SAME | NR2E3, NR3C1, NR0B2 | CYP1A2 1358/4885ESR2 15/4885ESR1 45/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.